Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
HSHeartSciences Inc. logo

HeartSciences Inc. (HSCS)

NASDAQ Capital Market · Currency in USD
$3.14 ▼ -0.03 (-0.95%)
At close: Oct 23, 4:00 PM ET. Market closed.
$3.12 ▼ -0.02 (-0.61%)
After hours: Oct 23, 6:24 PM ET

Summary

Previous Close
$3.17
Open
$3.17
Day's Range
$3.09 – $3.22
52 Week Range
$1.63 – $5.25
Volume
21,836
Avg. Volume
2,302,803
Market Cap
$15.21M
Beta (5Y Monthly)
1.78
PE Ratio (TTM)
--
EPS (TTM)
-$2.80
Earnings Date
Dec 21, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$3.00

Profile: HeartSciences Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
14
CEO
Andrew Simpson

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination.

Earnings

Next report: Mon, Dec 21, 2026
EPS estimate -$0.62 · Revenue est. $100.00K
DateEst.Actual
Sep 16, 2026-$0.72-$0.86Miss
Jul 23, 2026-$0.66-$0.88Miss
Mar 16, 2026-$0.84-$0.63Beat
Dec 15, 2025-$0.90-$0.85Beat
Sep 11, 2025-$2.41-$1.58Beat
Jul 24, 2025-$2.51-$1.88Beat

Analyst view

Consensus price target
$3.00 ▼ -4.5%
Range $3.00 – $3.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on HSCS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.